Ratings HCA Healthcare, Inc.

Equities

HCA

US40412C1018

Market Closed - Nyse Other stock markets 01:30:02 14/09/2024 am IST			5-day change	1st Jan Change
394.68 ^USD	+0.77%		+1.73%	+45.81%

12/09	Hca Healthcare Insider Sold Shares Worth $3,221,340, According to a Recent SEC Filing	MT
05/09	Transcript : HCA Healthcare, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 03:20 PM

Summary: HCA Healthcare, Inc.

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company presents an interesting fundamental situation from a short-term investment perspective.

Highlights: HCA Healthcare, Inc.

Over the past year, analysts have regularly revised upwards their sales forecast for the company.
Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
For the past twelve months, EPS forecast has been revised upwards.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
The group usually releases upbeat results with huge surprise rates.

Weaknesses: HCA Healthcare, Inc.

The group shows a rather high level of debt in proportion to its EBITDA.
The company is not the most generous with respect to shareholders' compensation.

Ratings Chart: HCA Healthcare, Inc.

Source: Surperformance

ESG chart: HCA Healthcare, Inc.

Source: Refinitiv

Sector Comparison:

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Valuation	Capi. ($)
HCA HEALTHCARE, INC.		102B
CVS HEALTH CORPORATION		72.94B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY		27.7B
FRESENIUS SE & CO. KGAA		21.55B
LABCORP HOLDINGS INC.		18.57B
QUEST DIAGNOSTICS INCORPORATED		17.19B
NATERA, INC.	-	15.65B
TENET HEALTHCARE CORPORATION		15.56B
UNIVERSAL HEALTH SERVICES, INC.		15.51B
REDE D'OR SÃO LUIZ S.A.		14.05B
Average		32.06B
Weighted average by Cap.

See all sector ratings

Investor Rating

Trading Rating

ESG Refinitiv

C+

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes